Encelimab is an anti-LAG3 антитело. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-клетка activation. Encelimab alone or in combination with an anti-PD-1 антитело reduces tumor size in a lymphoma mice model (A20 клетка xenograft).
Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.